Key points from article :
To develop and commercialize medicines aimed at restoring a healthy bacteriological balance in the human digestive system.
Drug would soon be going into clinical trial in Europe
Treatments target disorders of the microbiome which lead to conditions such as ulcerative colitis, Crohn’s disease and CDI.
